Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Current Deferred Revenue (2016 - 2019)

CorMedix (CRMD) has disclosed Current Deferred Revenue for 5 consecutive years, with $2206.0 as the latest value for Q4 2019.

  • Quarterly Current Deferred Revenue fell 80.0% to $2206.0 in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $2206.0 through Dec 2019, down 80.0% year-over-year, with the annual reading at $2206.0 for FY2019, 80.0% down from the prior year.
  • Current Deferred Revenue hit $2206.0 in Q4 2019 for CorMedix, down from $4400.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $132611.0 in Q2 2016 to a low of $2206.0 in Q4 2019.
  • Historically, Current Deferred Revenue has averaged $52911.8 across 5 years, with a median of $19870.0 in 2016.
  • Biggest five-year swings in Current Deferred Revenue: skyrocketed 291.98% in 2017 and later plummeted 87.52% in 2018.
  • Year by year, Current Deferred Revenue stood at $130409.0 in 2015, then decreased by 20.09% to $104210.0 in 2016, then decreased by 15.17% to $88404.0 in 2017, then tumbled by 87.52% to $11029.0 in 2018, then plummeted by 80.0% to $2206.0 in 2019.
  • Business Quant data shows Current Deferred Revenue for CRMD at $2206.0 in Q4 2019, $4400.0 in Q3 2019, and $6618.0 in Q2 2019.